These are particularly suitable for metastatic CRC patients requiring RAS and BRAF gene typing [60].Despite multiple MSI algorithms, the lack of a unified standard has led to challenges in standardizing NGS MSI testing. Here, BRAF is linked to colorectal carcinoma.